Vanguard Group's Interest in Spire Healthcare

The Vanguard Group, Inc. has made public its positions in Spire Healthcare Group plc, in accordance with Rule 8.3 of the Takeover Code. The disclosure reveals Vanguard's interest in relevant securities of Spire Healthcare as of November 12, 2025. Vanguard controls 14,385,601 ordinary shares, representing 3.57% of Spire's securities. Recently, Vanguard sold 12,807 of these securities at a price of 2.28 GBP per unit.

No cash-settled derivative transactions or stock-settled derivative activities were disclosed. Furthermore, Vanguard stated that there are no agreements or understandings involving inducements for handling these securities. The document also confirmed there are no attachments relating to open stock-settled derivative positions. This disclosure is part of Vanguard's regulatory obligations under the Takeover Code.